Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julie Overbaugh

Showing results (81-90 of 269) with videos related to

Pageof 27
Sort By:
The Journal of Infectious Diseases|June 8, 2004
Cyclic shedding of HIV-1 RNA in cervical secretions during the menstrual cycleSarah Benki, Sara B Mostad, Barbra A Richardson, et al.
Journal of Virology|May 29, 2009
Cross-subtype neutralization sensitivity despite monoclonal antibody resistance among early subtype A, C, and D envelope variants of human immunodeficiency virus type 1Catherine A Blish, Zahra Jalalian-Lechak, Stephanie Rainwater, et al.
International Journal of STD & AIDS|September 28, 2019
Virological failure in children living with HIV on antiretroviral therapy: correlates and predictive value of clinical measurements and CD4 cell countLaura P Newman, Jade Pagkas-Bather, Anne Njoroge, et al.
Journal of Virology|January 28, 2006
Envelope determinants for dual-receptor specificity in feline leukemia virus subgroup A and T variantsHeather H Cheng, Maria M Anderson, F Claire Hankenson, et al.
Journal of Medical Primatology|August 3, 2007
Immunogenicity and protective efficacy of Gag/Pol/Env vaccines derived from temporal isolates of SIVmne against cognate virus challengePatricia Polacino, Brad Cleveland, Yongde Zhu, et al.
Journal of Virology|June 15, 2004
Human immunodeficiency virus type 1 (HIV-1) diversity at time of infection is not restricted to certain risk groups or specific HIV-1 subtypesManish Sagar, Erin Kirkegaard, E Michelle Long, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 4, 2005
The early work on hormonal contraceptive use and HIV acquisitionHarold L Martin, Barbra A Richardson, Kishorchandra Mandaliya, et al.
AIDS Research and Human Retroviruses|October 15, 2014
Short communication: Fc gamma receptors IIa and IIIa genetic polymorphisms do not predict HIV-1 disease progression in Kenyan womenJulie F Weis, R Scott McClelland, Walter Jaoko, et al.
AIDS (London, England)|December 3, 2009
Illness during pregnancy and bacterial vaginosis are associated with in-utero HIV-1 transmissionCarey Farquhar, Dorothy Mbori-Ngacha, Julie Overbaugh, et al.
Virology Journal|August 6, 2008
Heavily glycosylated, highly fit SIVMne variants continue to diversify and undergo selection after transmission to a new host and they elicit early antibody dependent cellular responses but delayed neutralizing antibody responsesDawnnica Eastman, Anne Piantadosi, Xueling Wu, et al.
Pageof 27

Showing results (81-90 of 269) with videos related to

Sort By:
Pageof 27
The Journal of Infectious Diseases|June 8, 2004
Cyclic shedding of HIV-1 RNA in cervical secretions during the menstrual cycleSarah Benki, Sara B Mostad, Barbra A Richardson, et al.
Journal of Virology|May 29, 2009
Cross-subtype neutralization sensitivity despite monoclonal antibody resistance among early subtype A, C, and D envelope variants of human immunodeficiency virus type 1Catherine A Blish, Zahra Jalalian-Lechak, Stephanie Rainwater, et al.
International Journal of STD & AIDS|September 28, 2019
Virological failure in children living with HIV on antiretroviral therapy: correlates and predictive value of clinical measurements and CD4 cell countLaura P Newman, Jade Pagkas-Bather, Anne Njoroge, et al.
Journal of Virology|January 28, 2006
Envelope determinants for dual-receptor specificity in feline leukemia virus subgroup A and T variantsHeather H Cheng, Maria M Anderson, F Claire Hankenson, et al.
Journal of Medical Primatology|August 3, 2007
Immunogenicity and protective efficacy of Gag/Pol/Env vaccines derived from temporal isolates of SIVmne against cognate virus challengePatricia Polacino, Brad Cleveland, Yongde Zhu, et al.
Journal of Virology|June 15, 2004
Human immunodeficiency virus type 1 (HIV-1) diversity at time of infection is not restricted to certain risk groups or specific HIV-1 subtypesManish Sagar, Erin Kirkegaard, E Michelle Long, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 4, 2005
The early work on hormonal contraceptive use and HIV acquisitionHarold L Martin, Barbra A Richardson, Kishorchandra Mandaliya, et al.
AIDS Research and Human Retroviruses|October 15, 2014
Short communication: Fc gamma receptors IIa and IIIa genetic polymorphisms do not predict HIV-1 disease progression in Kenyan womenJulie F Weis, R Scott McClelland, Walter Jaoko, et al.
AIDS (London, England)|December 3, 2009
Illness during pregnancy and bacterial vaginosis are associated with in-utero HIV-1 transmissionCarey Farquhar, Dorothy Mbori-Ngacha, Julie Overbaugh, et al.
Virology Journal|August 6, 2008
Heavily glycosylated, highly fit SIVMne variants continue to diversify and undergo selection after transmission to a new host and they elicit early antibody dependent cellular responses but delayed neutralizing antibody responsesDawnnica Eastman, Anne Piantadosi, Xueling Wu, et al.
Pageof 27